These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 1350665)
1. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Deutch AY; Cameron DS Neuroscience; 1992; 46(1):49-56. PubMed ID: 1350665 [TBL] [Abstract][Full Text] [Related]
2. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens. Boldry RC; Uretsky NJ Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677 [TBL] [Abstract][Full Text] [Related]
3. Effects of psychological stress on monoamine systems in subregions of the frontal cortex and nucleus accumbens of the rat. Noguchi T; Yoshida Y; Chiba S Brain Res; 2001 Oct; 916(1-2):91-100. PubMed ID: 11597595 [TBL] [Abstract][Full Text] [Related]
4. Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol. Karoum F; Egan MF Br J Pharmacol; 1992 Mar; 105(3):703-7. PubMed ID: 1628156 [TBL] [Abstract][Full Text] [Related]
5. The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis. Ichikawa J; Meltzer HY Eur J Pharmacol; 1990 Feb; 176(3):371-4. PubMed ID: 2184042 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum. Rivest R; Marsden CA Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367 [TBL] [Abstract][Full Text] [Related]
7. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157 [TBL] [Abstract][Full Text] [Related]
8. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine. Mignot E; Laude D J Neurochem; 1985 Nov; 45(5):1527-33. PubMed ID: 2864397 [TBL] [Abstract][Full Text] [Related]
9. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Bardgett ME; Salaris SL; Jackson JL; Harding J; Csernansky JG Psychopharmacology (Berl); 1997 Sep; 133(2):142-51. PubMed ID: 9342780 [TBL] [Abstract][Full Text] [Related]
10. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats. Fulford AJ; Marsden CA Neuroscience; 2007 Oct; 149(2):392-400. PubMed ID: 17869434 [TBL] [Abstract][Full Text] [Related]
11. Loss of dopamine terminals in the medial prefrontal cortex increased the ratio of DOPAC to DA in tissue of the nucleus accumbens shell: role of stress. King D; Finlay JM Brain Res; 1997 Sep; 767(2):192-200. PubMed ID: 9367247 [TBL] [Abstract][Full Text] [Related]
12. Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol. Rivest R; Marsden CA Br J Pharmacol; 1991 Sep; 104(1):234-8. PubMed ID: 1786513 [TBL] [Abstract][Full Text] [Related]
13. Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142. Horger BA; Elsworth JD; Roth RH J Neurochem; 1995 Aug; 65(2):770-4. PubMed ID: 7616234 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens. Ichikawa J; Meltzer HY J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232 [TBL] [Abstract][Full Text] [Related]
15. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism. Gray AM; Connick JH Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162 [TBL] [Abstract][Full Text] [Related]
16. 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. Karoum F; Chrapusta SJ; Egan MF J Neurochem; 1994 Sep; 63(3):972-9. PubMed ID: 7914228 [TBL] [Abstract][Full Text] [Related]
17. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat. Mignot E; Laude D; Elghozi JL J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472 [TBL] [Abstract][Full Text] [Related]
18. Chronic clozapine, but not haloperidol, alters the response of mesoprefrontal dopamine neurons to stress and clozapine challenges in rats. Morrow BA; Rosenberg SJ; Roth RH Synapse; 1999 Oct; 34(1):28-35. PubMed ID: 10459169 [TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats. Invernizzi R; Morali F; Pozzi L; Samanin R Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499 [TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. King D; Zigmond MJ; Finlay JM Neuroscience; 1997 Mar; 77(1):141-53. PubMed ID: 9044382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]